Uric acid relationships with lipid profile and adiposity indices: Impact of different hyperuricemic thresholds

J Clin Hypertens (Greenwich). 2023 Jan;25(1):78-85. doi: 10.1111/jch.14613. Epub 2022 Dec 27.

Abstract

Previous studies focused on the relationships between Serum Uric Acid (SUA) and lipids have found an association mainly with triglycerides. Furthermore, previous studies on adiposity indices have been focused on the evaluation of the Visceral Adiposity Index (VAI). The present study was aimed at providing within the same population a systematic evaluation of lipids and adiposity indices with SUA, employing both the classic cutoff for hyperuricemia and the newly one identified by the Uric Acid Right for Heart Health (URRAH) study. We analyzed data collected in 1892 subjects of the Pressioni Arteriose Monitorate E loro Associazioni (PAMELA) study with available SUA, lipid profile and variables necessary to calculate VAI, Cardio-Metabolic Index (CMI) and Lipid Accumulation Product (LAP). At linear regression model (corrected for confounders) SUA correlated with all the lipids values (with the strongest β for triglycerides) and adiposity indices. When the two different cutoffs were compared, the URRAH one was significantly related to atherogenic lipids profile (OR 1.207 for LDL and 1.33 for non-HDL, P < 0.001) while this was not the case for the classic one. Regarding adiposity indices the classic cutoff displays highest OR as compared to the URRAH one. In conclusions, newly reported URRAH cutoff for hyperuricemia better relate to atherogenic lipoprotein (LDL and non-HDL) when compared to the classic one. The opposite has been found for adiposity indexes where the classic cut-off seems to present highest performance. Among adiposity indexes, LAP present the highest OR for the relationship with hyperuricemia.

Keywords: adiposity indices; cardiometabolic index; lipid accumulation product; lipids; uric acid; visceral adiposity index.

MeSH terms

  • Adiposity
  • Body Mass Index
  • Humans
  • Hypertension* / complications
  • Hyperuricemia* / complications
  • Obesity / complications
  • Obesity, Abdominal / epidemiology
  • Triglycerides
  • Uric Acid

Substances

  • Uric Acid
  • Triglycerides